The article features ImThera Medical Inc., a start-up manufacturer of neuromodulation devices based in San Diego, California. It describes aura6000, a multi-contact electrode connected to a programmable pulse generator developed by the company. It explores the target market of the device and the ...
ImThera Medical’s Aura6000 Implantable System for the Treatment of Sleep Apnea Posted on December 20, 2011 by David Prutchi Posted in ImThera Medical, Obstructive Sleep Apnea, Rechargeable Batteries, Sleep Apnea Image Credit: Imthera The aura6000 is based on ImThera’s Targeted Hypoglossal ...
IMTHERA商标注册申请 申请/注册号:8634094申请日期:2010-09-03国际分类:第10类-医疗器械商标申请人:益姆希拉医疗有限公司;IMTHERAMEDICAL,INC.办理/代理机构:陈韵云知识产权代理(北京)有限公司爱企查 关于我们用户协议免责声明 友情链接:爱采购加盟星 联系我们 用户反馈:点此反馈 商务合作:bd-aiqicha@baidu.com ...
ImThera Medical Successfully Implants First Patients With Neurostimulation Device To Treat OSA
ImThera Medical Completes Development Of Targeted Hypoglossal Neurostimulation Treatment For OSA
ImThera Medical Reports Interim Data From OSA Neurostimulation European Clinical Study
The article presents information on ImThera Medical's aura6000 neurostimulation device for treating tongue-based Obstructive Sleep Apnea (OSA). To evaluate the effectiveness of the product in the treatment of obstructive sleep apnea, the company has conducted a pilot study with implantation of the ...
ImThera releases data from OSA clinical study. (cover story)The article reports on the release of preliminary data from six of the 10 patients in the obstructive sleep apnea (OSA) European clinical study by ImThera Medical. The patients used the aura6000, a neurostimulation therapy developed by...
ImThera earns CE mark for the aura6000The article reports that a European Conformity (CE) mark approval has been granted to the aura6000 system of ImThera Medical for the treatment of obstructive sleep apnea (...
The article reports that ImThera Medical has completed development and will start human trials of its targeted hypoglossal neurostimulation (THN) system for obstructive sleep apnea (OSA) in October 2009. The human trials are geared toward the non-compliant continuous positive airway pressure (CPAP) ...